lactic acid has been researched along with cpi 613 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dvořák, A; Koncošová, M; Křížová, I; Rimpelová, S; Ruml, T; Rumlová, M; Tomášová, P; Vítek, L; Vrzáčková, N; Zelenka, J | 1 |
| Goldstein, L; Joksch, M; Krause, B; Kumstel, S; Lindner, T; Schönrogge, M; Schreiber, T; Stenzel, J; Vollmar, B; Wendt, EHU; Zechner, D; Zhang, X | 1 |
2 other study(ies) available for lactic acid and cpi 613
| Article | Year |
|---|---|
Inhibition of Mitochondrial Metabolism Leads to Selective Eradication of Cells Adapted to Acidic Microenvironment.
Topics: Acidosis; Adaptation, Physiological; Antineoplastic Agents; Caprylates; Citric Acid Cycle; Energy Metabolism; Glucose; Glycolysis; Humans; Hydrogen-Ion Concentration; Lactic Acid; Mitochondria; Neoplasms; Oxidative Stress; Sulfides; Tumor Cells, Cultured; Tumor Microenvironment | 2021 |
Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism.
Topics: Animals; Caprylates; Cell Line, Tumor; Humans; Lactic Acid; Mice; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Sulfides | 2022 |